期刊文献+

KDR靶向RNA干扰对MCF-7细胞凋亡的影响(英文) 被引量:2

Apoptosis Effect of RNAi Targeting KDR on MCF-7 Cells
原文传递
导出
摘要 目的:研究KDR靶向RNA干扰对MCF-7细胞凋亡的影响,探讨其可能的机制。方法:采用阳离子脂质体Lipofecta-mine2000TM作为转染试剂将人KDR基因的siRNA转染人类乳腺细胞株MCF-7,诱RNAi,采用Hoechst33258染色和半定量RT-PCR检测Caspase-3、survivin的mRNA表达及细胞凋亡变化;比色法检测Caspase-3的活性;利用免疫组织化学方法检测survivin的表达,并用图像分析仪分析蛋白表达强度。结果:靶向KDR的siRNA转染MCF-7后,Caspase-3的mRNA表达上调,survivin基因mRNA及蛋白表达水平下调(P<0.05)。结论:KDRsiRNA通过减少乳腺癌细胞survivin的表达,增加Caspase-3表达来促进肿瘤细胞凋亡,发挥其抗肿瘤作用。 Objective: To investigate the apoptosis effect of small interfering RNA (siRNA) targeting kinase insert domain-containing receptor (KDR) on MCF-7 cells and to investigate the possible mechanisms. Methods: KDR-siRNA was chemically synthesized and transfected into MCF-7 cells by cationic liposome Lipofectamine2000TM. Cell apoptosis was measured by Hoechst33258 staining; The expression ofCaspase-3 mRNA and survivin mRNA was detected by semi-quantitative RT-PCR; Caspase-3 activity was measured by colorimetry; The expression of survivin protein was detected by immunohistochemistry and analyzed by the image analyzer. Result.s: siRNA effectively knocked-down KDR gene. KDR-siRNA enhanced the expression of Caspase-3 and down-regulated the expression of survivin (p〈0.05). Conclusions: KDR-siRNA induced tumor cells apoptosis by increasing the expression of Caspase-3 and decreasing the expression of survivin.
出处 《现代生物医学进展》 CAS 2009年第20期3864-3867,F0002,共5页 Progress in Modern Biomedicine
基金 Qingdao Science and Technology Project (No. 07-2-1-7-nsh)~~
关键词 SIRNA MCF.7细胞 血管内皮生长因子受体2 凋亡 基因治疗 siRNA MCF-7 VEGFR-2 Apoptosis Gene therapy
  • 相关文献

参考文献2

二级参考文献14

  • 1安立峰,董震.RNA干扰——肿瘤研究的新工具[J].中华肿瘤杂志,2005,27(7):385-388. 被引量:38
  • 2Shinkaruk S, Bayle M, lain G, et al. Vascular endothelial cell growth factor (VEGF) , an emerging target for cancer chemotherapy[J]. Curr Med Chem Anticancer Agents, 2003, 3 (2) : 95 - 117.
  • 3Masood R, Cai J, Zheng T, et al. Vascular endothelial growth factor (VEGF) is an autocrine growth factor for VEGF receptor-positive human tumors[J]. Blood, 2001,98(6) : 1904-1913.
  • 4de Jong JS, van Diest PJ, van der Valk P, et al. Expression of growth factors, growth-inhibiting factors, and their receptors in invasive breast cancer, Ⅱ: Correlations with proliferation and Angiogenesis [ J ]. J Pathol, 1998, 184( 1 ) : 53 -57.
  • 5Kasukabe T, Okabe-Kado J, Kato N, et al. Effects of combined treatment with rapamyein and eotylenin A, a novel differentiation-inducing agent, on human breast carcinoma MCF-7 cells and xenografts [ J ]. Breast Cancer Res, 2005, 7(6): R1097- 1110.
  • 6Ferrara N. VEGF: an update on biological and therapeutic aspects [J]. Curt Opin Biotechnol, 2000, 11(6) : 617 -624.
  • 7Lacal PM, Ruffini F, Pagani E, et al. An autocrine loop directed by the vascular endothelial growth factor promotes invasiveness of human melanoma cells[ J]. Int J Oncol, 2005, 27(6) : 1625 - 1632.
  • 8Dorsett Y, Tuschl T. siRNAs: applications in functional genomics and potential as therapeutics [ J ]. Nat Rev Drug Discov, 2004, 3 (4) : 318 -329.
  • 9Layzer JM, McCaffrey AP, Tanner AK, et al. In vivo activity of nuclease-resistant siRNAs[J]. RNA, 2004, 10(5): 766-771.
  • 10Schiffelers RM, Ansari A, Xu J, et al. Cancer siRNA therapy by tumor selective delivery with ligand-targeted sterically stabilized nanoparticle[J]. Nucleic Acids Res, 2004, 32(19) : 149.

共引文献21

同被引文献3

引证文献2

二级引证文献7

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部